Literature DB >> 10873921

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder.

J D Bremner1, R B Innis, S M Southwick, L Staib, S Zoghbi, D S Charney.   

Abstract

OBJECTIVE: Animals exposed to stress exhibit a decrease in benzodiazepine receptor binding in the frontal cortex. No studies have examined central benzodiazepine receptor binding in patients with posttraumatic stress disorder (PTSD). The purpose of this study was to examine measures of benzodiazepine receptor binding in PTSD.
METHOD: From 13 patients with Vietnam combat-related PTSD and 13 case-matched healthy comparison subjects, a quantitative measure related to benzodiazepine receptor binding (distribution volume) was obtained with single photon emission computed tomography (SPECT) imaging of [(123)I]iomazenil binding and measurement of radioligand concentration in plasma. Distribution volume image data were analyzed by means of statistical parametric mapping.
RESULTS: Lower distribution volumes were found in the prefrontal cortex (Brodmann's area 9) of PTSD patients than in comparison subjects.
CONCLUSIONS: These findings of lower values for the benzodiazepine receptor binding measure of distribution volume are consistent with fewer benzodiazepine receptors and/or reduced affinity of receptor binding in the medial prefrontal cortex in patients with PTSD. Alterations in benzodiazepine receptor function in this area may underlie many of the symptoms of PTSD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873921     DOI: 10.1176/appi.ajp.157.7.1120

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  57 in total

Review 1.  Facial expressions, their communicatory functions and neuro-cognitive substrates.

Authors:  R J R Blair
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-03-29       Impact factor: 6.237

Review 2.  Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.

Authors:  Xia Chen; Joop van Gerven; Adam Cohen; Gabriel Jacobs
Journal:  Acta Pharmacol Sin       Date:  2018-12-05       Impact factor: 6.150

Review 3.  Neuroimaging studies in post-traumatic stress disorder.

Authors:  J Douglas Bremner
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

4.  [Medical aspects of objectifying torture sequels].

Authors:  Siroos Mirzaei; Peter Knoll; Horst Köhn
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

5.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

6.  Possible GABAergic modulation in the protective effect of zolpidem in acute hypoxic stress-induced behavior alterations and oxidative damage.

Authors:  Anil Kumar; Richa Goyal
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

Review 7.  Stress and brain atrophy.

Authors:  J Douglas Bremner
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-10       Impact factor: 4.388

Review 8.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

9.  GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

Authors:  Jamie Maguire; Istvan Mody
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

10.  Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABA(A) receptors.

Authors:  Sarah J Bailey; Miklos Toth
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.